Story perspectives

Hims & Hers Hit by Lawsuits After Novo Nordisk Split

7/20/2025

23 1

Summary

Story summary

Hims & Hers Health, Inc. is facing lawsuits after ending its partnership with Novo Nordisk over alleged deceptive marketing.
Securities class action lawsuits accuse the company and executives of misleading investors about compliance and practices.
A derivative lawsuit claims board members neglected regulatory risks and misled investors about the partnership's stability.
The lawsuits follow a significant stock price drop linked to Novo Nordisk's accusations of illegal practices.
These legal challenges underscore important regulatory concerns in the telehealth sector regarding compounding pharmacies and patient safety.

1 of 1

Story summary

Hims & Hers Health, Inc. is facing lawsuits after ending its partnership with Novo Nordisk over alleged deceptive marketing.
Securities class action lawsuits accuse the company and executives of misleading investors about compliance and practices.
A derivative lawsuit claims board members neglected regulatory risks and misled investors about the partnership's stability.
The lawsuits follow a significant stock price drop linked to Novo Nordisk's accusations of illegal practices.
These legal challenges underscore important regulatory concerns in the telehealth sector regarding compounding pharmacies and patient safety.